Patient blood management to reduce surgical risk

British Journal of Surgery

Volumn 102, Issue 11, 2015, Pages 1325-1337

  Clevenger, B ^a,b   Mallett, S V ^a,b   Klein, A A ^c   Richards, T ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COMPLICATION; ELECTIVE SURGERY; HUMAN; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PROCEDURES; RISK FACTOR;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; ELECTIVE SURGICAL PROCEDURES; HUMANS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PREOPERATIVE PERIOD; RISK FACTORS;

EID: 84941186830     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9898     Document Type: Review

References (77)

1. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al,. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-1407.
2. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB,. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49-55.
3. Hofmann A, Farmer S, Shander A,. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management. Oncologist 2011; 16: 3-11.
4. Spahn DR, Theusinger OM, Hofmann A,. Patient blood management is a win-win: a wake-up call. Br J Anaesth 2012; 108: 889-892.
5. Tobler LH, Busch MP,. History of posttransfusion hepatitis. Clin Chem 1997; 43: 1487-1493.
6. World Health Organization. Availability, safety and quality of blood products. Report by the Secretariat. Agenda item 11.17. Sixty-third World Health Assembly WHA63/20. WHO: Geneva, 2010; 25.
7. Shander A, Van Aken H, Colomina MJ, Gombotz H, Hofmann A, Krauspe R, et al,. Patient blood management in Europe. Br J Anaesth 2012; 109: 55-68.
8. JPAC-Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. Patient Blood Management; 2014. http://www.transfusionguidelines.org.uk/uk-transfusion-committees/national-blood-transfusion-committee/patient-blood-management [accessed 1 October 2014].
9. Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A,. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol 2013; 27: 59-68.
10. Lasocki S, Krauspe R, von Heymann C, Mezzacasa A, Chainey S, Spahn DR,. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery. A multicentre observational study. Eur J Anaesthesiol 2015; 32: 160-167.
11. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, et al,. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114: 283-292.
12. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB,. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-937.
13. JPAC-Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. Transfusion Handbook 5th Edition: January 2014. http://www.transfusionguidelines.org.uk/transfusion-handbook [accessed 1 October 2014].
14. Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, et al,. Age of transfused blood in critically ill adults. N Engl J Med 2015; 372: 1410-1418.
15. Kaukonen KM, Bailey M, Ady B, Aubron C, French C, Gantner D, et al,. A randomised controlled trial of standard transfusion versus fresher red blood cell use in intensive care (TRANSFUSE): protocol and statistical analysis plan. Crit Care Resusc 2014; 16: 255-261.
16. Acheson AG, Brookes MJ, Spahn DR,. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery. Ann Surg 2012; 256: 235-244.
17. Bolton-Maggs PHB, (ed.), Poles D, Watt A, Thomas D, Cohen H,; Serious Hazards of Transfusion (SHOT) Steering Group. Annual SHOT Report 2012; 2013. http://www.shotuk.org/wp-content/uploads/2013/08/SHOT-Annual-Report-2012.pdf [accessed 1 October 2014].
18. Shander A, Knight K, Thurer R, Adamson J, Spence R,. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 116: 58S-69S.
19. Geisel T, Martin J, Schulze B, Schaefer R, Bach M, Virgin G, et al,. An etiologic profile of anemia in 405 geriatric patients. Anemia 2014; 2014: 932486.
20. Hung M, Besser M, Sharples LD, Nair SK, Klein AA,. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia 2011; 66: 812-818.
21. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD,. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-2552.
22. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM,. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 2002; 102: 237-244.
23. Beattie WS, Karkouti K, Wijeysundera DN, Tait G,. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-581.
24. Lin DM, Lin ES, Tran MH,. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus Med Rev 2013; 27: 221-234.
25. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al,. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-2488.
26. Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK,. Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg 2011; 212: 187-194.
27. Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, et al,.; European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 2014; 113: 416-423.
28. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, et al,. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2010; 106: 13-22.
29. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al,. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382.
30. Busti F, Campostrini N, Martinelli N, Girelli D,. Iron deficiency in the elderly population, revisited in the hepcidin era. Front Pharmacol 2014; 5: 83.
31. Hung M, Ortmann E, Besser M, Martin-Cabrera P, Richards T, Ghosh M, et al,. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart 2015; 101: 107-112.
32. Clevenger B, Richards T,. Preoperative anaemia. Anaesthesia 2015; 70 (Suppl 1): 20-28, e6-e8.
33. Goddard AF, James MW, McIntyre AS, Scott BB; British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut 2011; 60: 1309-1316.
34. Meybohm P, Fischer DP, Geisen C, Müller MM, Weber CF, Herrmann E, et al,. German PBM Study Core Group. Safety and effectiveness of a patient blood management (PBM) program in surgical patients-the study design for a multi-centre prospective epidemiologic non-inferiority trial. BMC Health Serv Res 2014; 14: 576.
35. Gurusamy KS, Nagendran M, Broadhurst JF, Anker SD, Richards T,. Iron therapy in anaemic adults without chronic kidney disease. Cochrane Database Syst Rev 2014; (12)CD010640.
36. Tolkien Z, Stecher L, Mander AP, Pereira DIA, Powell JJ,. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One 2015; 10: e0117383.
37. Auerbach M, Goodnough LT, Shander A,. Iron: the new advances in therapy. Best Pract Res Clin Anaesthesiol 2013; 27: 131-140.
38. Litton E, Xiao J, Ho KM,. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ 2013; 347: f4822.
39. Devon KM, McLeod RS,. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database Syst Rev 2009; (1)CD007148.
40. Laupacis A, Fergusson D,. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-Operative Transfusion (ISPOT) Investigators. Transfus Med 1998; 8: 309-317.
41. Alghamdi AA, Albanna MJ, Guru V, Brister SJ,. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Cardiac Surgery 2006; 21: 320-326.
42. Rineau E, Chaudet A, Carlier L, Bizot P, Lasocki S,. Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery. Br J Anaesth 2014; 113: 296-298.
43. Unger EF, Thompson AM, Blank MJ, Temple R,. Erythropoiesis-stimulating agents-time for a reevaluation. N Engl J Med 2010; 362: 189-192.
44. Pascual M, Bohle B, Alonso S, Mayol X, Salvans S, Grande L, et al,. Preoperative administration of erythropoietin stimulates tumor recurrence after surgical excision of colon cancer in mice by a vascular endothelial growth factor. J Surg Res 2013; 183: 270-277.
45. Kasivisvanathan R, Abbassi-Ghadi N, Kumar S, Mackenzie H, Thompson K, James K, et al,. Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery. Br J Surg 2014; 101: 1383-1390.
46. Gill R., Practical management of major blood loss. Anaesthesia 2015; 70 (Suppl 1): 54-57, e19-e20.
47. Mallett SV, Armstrong M,. Point-of-care monitoring of haemostasis. Anaesthesia 2015; 70 (Suppl 1): 73-77, e25-e26.
48. Schöchl H, Voelckel W, Schlimp CJ,. Management of traumatic haemorrhage-the European perspective. Anaesthesia 2015; 70 (Suppl 1): 102-107, e35-e37.
49. Richman JM, Rowlingson AJ, Maine DN, Courpas GE, Weller JF, Wu CL,. Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. J Clin Anesth 2006; 18: 427-435.
50. Rajagopalan S, Mascha E, Na J, Sessler DI,. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 2008; 108: 71-77.
51. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al,. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; (3)CD001886.
52. Ortmann E, Besser MW, Klein AA,. Antifibrinolytic agents in current anaesthetic practice. Br J Anaesth 2013; 111: 549-563.
53. Ker K, Prieto-Merino D, Roberts I,. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 2013; 100: 1271-1279.
54. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al,. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
55. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al,.; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-2331.
56. McMullan V, Alston RP III,. Aprotinin and cardiac surgery: a sorry tale of evidence misused. Br J Anaesth 2013; 110: 675-678.
57. Carless PA, Henry DA, Anthony DM,. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 2013; (2)CD004171.
58. Ker K, Beecher D, Roberts I,. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev 2013; (7)CD010562.
59. Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C,. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006; 10: 1-210.
60. Ashworth A, Klein AA,. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010; 105: 401-416.
61. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA,. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010; (4)CD001888.
62. Feltracco P, Michieletto E, Barbieri S, Serra E, Rizzi S, Salvaterra F, et al,. Microbiologic contamination of intraoperative blood salvaged during liver transplantation. Transplant Proc 2007; 39: 1889-1891.
63. Bowley DM, Barker P, Boffard KD,. Intraoperative blood salvage in penetrating abdominal trauma: a randomized, controlled trial. World J Surg 2006; 30: 1074-1080.
64. Segal JB, Blasco Colmenares E, Norris EJ, Guallar E,. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004; 44: 632-644.
65. Parker MJ, Roberts CP, Hay D,. Closed suction drainage for hip and knee arthroplasty. A meta-analysis. J Bone Joint Surg Am 2004; 86-A: 1146-1152.
66. Bisbe E, Moltõ L, Arroyo R, Muniesa JM, Tejero M,. Randomized trial comparing ferric carboxymaltose versus oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth 2014; 113: 402-409.
67. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417.
68. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al,. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462.
69. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al,. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015; 385: 1183-1189.
70. Carson JL, Carless PA, Hébert PC,. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; (4)CD002042.
71. Villanueva C, Colomo A, Bosch A, Concepciõn M, Hernandez-Gea V, Aracil C, et al,. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
72. Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al,.; TITRe2 Investigators. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372: 997-1008.
73. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al,.; TRISS Trial Group; Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-1391.
74. Ma M, Eckert K, Ralley F, Chin-Yee I,. A retrospective study evaluating single-unit red blood cell transfusions in reducing allogeneic blood exposure. Transfusion Med 2005; 15: 307-312.
75. Murphy DJ, Pronovost PJ, Lehmann CU, Gurses AP, Whitman GJR, Needham DM, et al,. Red blood cell transfusion practices in two surgical intensive care units: a mixed methods assessment of barriers to evidence-based practice. Transfusion 2014; 54: 2658-2667.
76. Hare GMT, Tsui AK, Ozawa S, Shander A,. Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? Best Pract Res Clin Anaesthesiol 2013; 27: 85-98.
77. Meier J, Gombotz H,. Pillar III-optimisation of anaemia tolerance. Best Pract Res Clin Anaesthesiol 2013; 27: 111-119.